SCHEMBL3042437

SCHEMBL3042437

CCOC(=O)CNC(=O)NN

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.53
PPID Q08752 4/20 0.53
PPIB P23284 1/20 0.53
PPIA P62937 1/20 0.53
PPIG Q13427 1/20 0.53
MGAM O43451 1/20 0.50
SI P14410 1/20 0.50
MGAM2 Q2M2H8 1/20 0.50
EPHX2 P34913 2/20 0.47
ALDH1A1 P00352 5/20 0.45
NLRP3 Q96P20 1/20 0.45
HTT P42858 1/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
MMP3 P08254 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TSHR P16473 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7946756 0.87 PPID (0.62) GAAPPIDPPIBPPIAPPIG
SCHEMBL8144854 0.81 GAA (0.55) GAAPPIDPPIBPPIAPPIG
SCHEMBL8144848 0.81 GAA (0.55) GAAPPIDPPIBPPIAPPIG
SCHEMBL10470968 0.80 GAA (0.50) GAAPPIDPPIBPPIAPPIG
SCHEMBL16223208 0.79 PPID (0.60) GAAPPIDPPIBPPIAPPIG
SCHEMBL3309951 0.78 GAA (0.57) GAAPPIDPPIBPPIAPPIG
SCHEMBL182292 0.78
SCHEMBL7089973 0.78 GAA (0.61) GAAPPIDPPIBPPIAPPIG
SCHEMBL4220135 0.78 PPID (0.54) GAAPPIDPPIBPPIAPPIG
SCHEMBL14467616 0.78 PPID (0.54) GAAPPIDPPIBPPIAPPIG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708370-B2 Azapeptides as CD36 binding compounds VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2017-07-18 US disclosed
EP-2160404-B1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS VALORISATION RECHERCHE LTD PARTNERSHIP (CA) 2016-08-24 EP disclosed
US-20150329591-A1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE (CA) 2015-11-19 US disclosed
US-9115171-B2 Azapeptides as CD36 binding compounds VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2015-08-25 US disclosed
US-20130203686-A1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS INSERM (FR) 2013-08-08 US disclosed
US-8435954-B2 Azapeptides as CD36 binding compounds VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2013-05-07 US disclosed
US-20100210566-A1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2010-08-19 US disclosed
EP-2160404-A1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS UNIVERSITE DE MONTREAL (CA) 2010-03-10 EP disclosed
WO-2008154738-A1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS UNIVERSITE DE MONTREAL (CA) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329591-A1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS MSR1, ASGR1, LDLR GAA 165/4885PPID 4556/4885PPIB 3019/4885
US-20130203686-A1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS MSR1, ASGR1, SCARB1 GAA 234/4885PPID 4622/4885PPIB 3243/4885
US-20100210566-A1 AZAPEPTIDES AS CD36 BINDING COMPOUNDS GHRHR, GHSR, GNRHR GAA 401/4885PPID 4583/4885PPIB 3230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.